lexiara

2.

Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Text with EEA relevance) · European Union

The members of the MDSSG shall consist of a representative of the Agency, a representative of the Commission and one representative appointed by each Member State. The representatives of the Member States shall have expertise in the field of medical devices, as relevant. Those representatives may be the same as the representatives appointed to the Medical Devices Coordination Group established by Article 103 of Regulation (EU) 2017/745 (‘MDCG’), where appropriate. Members of the MDSSG may be accompanied to meetings of the MDSSG by experts in specific scientific or technical fields. The list of the members of the MDSSG shall be published on the Agency’s web portal. A representative of the PCWP and a representative of the HCPWP may attend meetings of the MDSSG as observers.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.